About |
Minervate Ltd. is a London-based healthtech company that has steadily carved its place among the most trusted innovators in clinical research and regulatory compliance. Born from a vision to merge technology and integrity, Minervate stands as a dynamic force driving the evolution of digital health systems across global pharmaceutical and biotechnology industries. Founded in 2017 by Lola Enape, an accomplished professional in quality assurance and regulatory compliance, the company embodies a commitment to making clinical data smarter, faster, and fully compliant with international standards.
At its core, Minervate believes that innovation and ethics should never exist on opposite sides of progress. In a time when the pace of drug development continues to accelerate, Minervate has built a foundation anchored in both technological sophistication and deep respect for GxP regulatory frameworks. From its early days as a consultancy focused on compliance and quality systems, the company has transformed into a full-fledged digital powerhouse, offering AI-driven platforms that revolutionize how organizations conduct, monitor, and validate clinical trials.
Minervate’s growth has been guided by a clear principle: that technology must serve science responsibly. Each solution is designed not merely to automate or accelerate processes but to strengthen data reliability, patient safety, and regulatory transparency. As the pharmaceutical landscape embraces digital transformation, Minervate stands as both a pioneer and a protector ensuring that every innovation remains accountable to the standards that safeguard patient welfare and scientific trust.
Under the leadership of Founder and CEO Lola Enape, Minervate continues to push the boundaries of what’s possible in healthtech. A FemTech champion and advocate for ethical AI, Enape has steered the company toward a vision where advanced analytics and compliance intelligence become seamless parts of clinical operations. Her philosophy “Minervate stands for innovation with integrity” has become the company’s guiding ethos, shaping its culture and influence across the industry.
Over the years, Minervate’s portfolio has expanded to include cutting-edge software, regulatory strategy, and quality management solutions tailored to pharmaceutical, biotech, and clinical research organizations worldwide. By blending its team’s regulatory expertise with emerging technologies, Minervate enables its clients to manage complex clinical data ecosystems without sacrificing precision or compliance. The company’s success is not measured solely by the speed of implementation but by the trust it builds with organizations navigating the rigorous demands of global health authorities such as the FDA, EMA, MHRA, and ANVISA.
Today, Minervate’s AI-powered clinical trial data solutions serve as the backbone of innovation for life science organizations seeking agility and confidence in data-driven decision-making. From remote and decentralized trials to highly regulated multi-site studies, Minervate provides the digital infrastructure that allows research teams to collect, validate, and analyze data efficiently while maintaining full traceability. The company’s technology ensures that every record every patient entry, every protocol adjustment, every lab result upholds the principles of data integrity that define successful clinical outcomes.
But beyond technology, Minervate’s greatest strength lies in its human foundation. Its team comprises experts in regulatory affairs, clinical operations, and digital systems design individuals united by a shared mission to harmonize compliance and innovation. The company’s collaborative culture encourages learning, diversity, and inclusion, recognizing that innovation thrives where multiple perspectives meet. This belief in inclusive leadership and collective intelligence continues to shape Minervate’s identity as a progressive, purpose-driven enterprise.
As Minervate prepares for its next chapter of growth, its recognition as a Web Summit 2025 Impact StartUp marks a milestone moment. This global acknowledgment celebrates Minervate’s role in transforming the intersection of technology and ethics within life sciences. The company’s participation at Web Summit reflects not just an achievement but a responsibility to continue setting new standards for digital compliance, AI-driven insights, and sustainable innovation.